Also known as: THC and male fertility · cannabis and sperm quality · marijuana and male reproductive health

Cannabis and Male Fertility

Regular cannabis use may lower sperm count; stopping is low-risk and evidence-supported.

Automated fact-check pass
8 cited sources
Published
Last reviewed
How this page was made

This article is for information only and is not medical advice. Talk to a doctor before using cannabis for a health condition, and do not stop or change prescribed treatment on your own.

↯ The honest take

The endocannabinoid system is active in testes and sperm, so a biological link exists. Human data show regular users tend to have lower sperm counts than non-users, but studies are observational and can't prove cannabis caused it. No evidence says cannabis improves fertility. Stopping for 3 months before conception is cautious and low-risk, since sperm regenerate on a 74-day cycle.

Not Medical Advice

This article is not medical advice. It summarizes published evidence as of October 2026. Male fertility is complex and highly individual. If you are trying to conceive, struggling to conceive, or have concerns about cannabis use and reproductive health, speak with a urologist, reproductive endocrinologist, or your primary care physician. Do not start, stop, or change cannabis use based on this article alone.

Plain-Language Summary

The endocannabinoid system is present throughout the male reproductive tract — in the testes, sperm cells, and in the hypothalamus and pituitary gland that regulate sex hormones [1][2]. That biological presence creates multiple plausible ways cannabis could affect fertility.

What the human data show: Regular cannabis users (typically defined as weekly or more frequent use) tend to have lower sperm concentration and total sperm count compared to non-users in several observational studies [3][4]. Findings on sperm movement (motility), shape (morphology), and hormone levels are inconsistent across studies. No study has shown cannabis improves fertility, and no randomized controlled trial has tested it as a fertility treatment.

The practical bottom line for men trying to conceive: the evidence is not strong enough to cause panic, but is substantial enough that 'reduce or stop cannabis for at least 3 months' is a reasonable, low-risk recommendation. Sperm cells regenerate on a cycle of approximately 74 days, so a three-month abstinence covers a full turnover.

What Probably Works for Male Fertility: Cannabis Is Not It

There is no evidence No data that cannabis, THC, CBD, or any cannabinoid improves male fertility. No randomized trial exists. No plausible clinical trial design has been proposed or conducted. No medical guideline recommends cannabis for this purpose.

What does have evidence for improving male fertility outcomes includes treating underlying medical causes (surgical repair of varicocele, correction of hormonal disorders), lifestyle changes (weight loss if obese, reducing alcohol and tobacco, increasing physical activity), and assisted reproductive technologies (intrauterine insemination, in vitro fertilization, intracytoplasmic sperm injection) [5]. These are the conversations to prioritize with a reproductive urologist or reproductive endocrinologist.

What Might Work: Stopping Cannabis

Since cannabis is not a treatment for fertility, the relevant question is whether stopping cannabis use might improve sperm parameters or conception rates in men who use it regularly. Direct evidence is sparse, but the biological rationale is plausible:

Cessation is low-cost and carries no direct medical risk (though cannabis withdrawal syndrome is real for heavy users). For men undergoing IUI or IVF, abstaining for at least the 3 months leading up to sperm collection is a standard recommendation in many fertility clinics, though direct evidence that it improves outcomes is limited.

What Doesn't Work or Has Weak Evidence

CBD alone for fertility. No human trials exist. Animal studies show mixed results and do not directly translate to humans No data.

'Sativa' strains being safer for sperm than 'indica' strains. The indica/sativa distinction is a marketing framework, not a reliable predictor of chemical composition or biological effect. See Cannabis Strain Name Reliability for detail No data.

Cannabis improving libido = improving fertility. Subjective arousal is not equivalent to sperm quality, hormonal function, or the ability to conceive. This is conflation, not evidence Anecdote.

Topical or suppository cannabis for 'reproductive health'. No clinical data support efficacy or safety for any reproductive outcome No data.

Specific THC dose thresholds being 'safe' for fertility. No study has established a dose below which no reproductive effect occurs, or above which effects are guaranteed No data.

The Actual Evidence on Reproductive Outcomes

Sperm concentration and count. A 2015 Danish study of 1,215 healthy young men found that regular cannabis use (more than once per week) was associated with 28% lower mean sperm concentration and 29% lower total sperm count compared to non-users [3]. A 2019 systematic review and meta-analysis pooling data from multiple studies also reported reductions in sperm concentration among cannabis users; however, heterogeneity between studies was substantial, and the magnitude of effect varied widely [4] Weak / limited.

Sperm motility and morphology. Results are mixed and inconsistent. Some studies report increased abnormal sperm morphology and reduced motility in cannabis users; others report no significant difference [4][7] Disputed.

Sex hormones (testosterone, LH, FSH). Acute THC administration can transiently lower testosterone and luteinizing hormone in some controlled studies. However, chronic effects in regular human users are inconsistent — some observational studies report lower testosterone in heavy users, others report no difference, and a small number report higher levels [2][7] Disputed.

Sperm DNA integrity and epigenetics. Emerging research suggests cannabis use may be associated with altered sperm DNA methylation patterns [8], but the clinical significance for offspring health is unknown and requires replication Weak / limited.

Erectile function. Survey data are conflicting. Some cross-sectional studies associate heavy cannabis use with erectile dysfunction; others find no association Disputed.

Major caveat: Nearly all human evidence is observational, not experimental. Cannabis users differ from non-users in multiple unmeasured ways — tobacco co-use, alcohol consumption, diet, body mass index, stress, sleep, physical activity. Even studies that adjust for known confounders cannot fully rule out residual confounding or reverse causality (e.g., men with underlying reproductive or hormonal disorders may use cannabis to cope with stress or low mood).

What We Don't Know

These gaps are substantial. Any claim of certainty beyond these bounds should be treated with skepticism.

Comparison With Standard Fertility Care

Standard evaluation of male subfertility includes semen analysis (sperm concentration, motility, morphology, and volume), serum hormone panel (testosterone, follicle-stimulating hormone, luteinizing hormone, prolactin), physical examination for varicocele, and sometimes genetic testing or scrotal ultrasound [5]. Treatment depends on the cause identified: surgical repair of varicocele, hormonal therapy for gonadotropin deficiency, lifestyle modification, and assisted reproductive technologies.

Cannabis has no established therapeutic role in this diagnostic and treatment pathway. Its only clinical relevance is as a modifiable risk factor — similar to tobacco, heavy alcohol use, or obesity — that a clinician may recommend you reduce or eliminate while pursuing evidence-based fertility treatment.

Risks and Practical Guidance

Beyond fertility, regular cannabis use carries documented health risks: cannabis use disorder (dependence) affects roughly 9% of users and up to 17% of those who start in adolescence, respiratory effects from smoking, cardiovascular effects, and impacts on mental health in vulnerable populations. These apply regardless of reproductive goals.

If you are trying to conceive: The evidence-based recommendation is to stop cannabis use at least 3 months before attempting conception, and certainly before scheduled sperm collection for intrauterine insemination or in vitro fertilization. The downside of stopping is low; the potential upside, while not definitively proven, is biologically plausible and consistent with general fertility medicine practice.

If you have unexplained male subfertility and use cannabis regularly: Disclose this to your urologist or reproductive endocrinologist. It is an inexpensive variable to modify.

If you are not trying to conceive: The fertility data alone are not a sufficient reason to quit cannabis. However, they are worth understanding, especially if you plan to father children in the future.

Again — this is not medical advice. It is a summary of imperfect evidence. Consult a clinician about your individual circumstances.

Sources

  1. Peer-reviewed Maccarrone M, et al. (2021). Endocannabinoid signaling in reproduction. Endocrine Reviews, 42(5), 596-624.
  2. Peer-reviewed du Plessis SS, Agarwal A, Syriac A. (2015). Marijuana, phytocannabinoids, the endocannabinoid system, and male fertility. Journal of Assisted Reproduction and Genetics, 32(11), 1575-1588.
  3. Peer-reviewed Gundersen TD, Jørgensen N, Andersson AM, et al. (2015). Association between use of marijuana and male reproductive hormones and semen quality: a study among 1,215 healthy young men. American Journal of Epidemiology, 182(6), 473-481.
  4. Peer-reviewed Payne KS, Mazur DJ, Hotaling JM, Pastuszak AW. (2019). Cannabis and male fertility: a systematic review. Journal of Urology, 202(4), 674-681.
  5. Peer-reviewed Practice Committee of the American Society for Reproductive Medicine. (2021). Diagnostic evaluation of the infertile male: a committee opinion. Fertility and Sterility, 115(1), 54-61.
  6. Peer-reviewed Rajanahally S, Raheem O, Rogers M, et al. (2019). The relationship between cannabis and male infertility, sexual health, and neoplasm: a systematic review. Andrology, 7(2), 139-147.
  7. Peer-reviewed Murphy SK, Itchon-Ramos N, Visco Z, et al. (2018). Cannabinoid exposure and altered DNA methylation in rat and human sperm. Epigenetics, 13(12), 1208-1221.
  8. Government National Academies of Sciences, Engineering, and Medicine. (2017). The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press.

How this page was made

Generation history

Oct 30, 2026
Revision
Oct 30, 2026
Fact-check pass — raised 6 flags
May 13, 2026
Fact-check pass — raised 3 flags
May 13, 2026
Initial draft

Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.